CY1106806T1 - Dna και πολυπεπτιδια ανθρωπινης tslp - Google Patents

Dna και πολυπεπτιδια ανθρωπινης tslp

Info

Publication number
CY1106806T1
CY1106806T1 CY20071101061T CY071101061T CY1106806T1 CY 1106806 T1 CY1106806 T1 CY 1106806T1 CY 20071101061 T CY20071101061 T CY 20071101061T CY 071101061 T CY071101061 T CY 071101061T CY 1106806 T1 CY1106806 T1 CY 1106806T1
Authority
CY
Cyprus
Prior art keywords
polypeptides
dna
human tslp
tslp polypeptides
purified
Prior art date
Application number
CY20071101061T
Other languages
English (en)
Inventor
John E. Sims
Stewart Lyman
Hilary Mckenna
Allison Armstrong
Original Assignee
Immunex Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22322307&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1106806(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Immunex Corporation filed Critical Immunex Corporation
Publication of CY1106806T1 publication Critical patent/CY1106806T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5418—IL-7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

Η εφεύρεση αφορά καθαρισμένα και απομονωμένα πρωτότυπα πολυπεπτίδια ΤSLΡ, τα νουκλεϊκά οξέα που κωδικοποιούν αυτά τα πολυπεπτίδια, διαδικασίες για παραγωγή ανασυνδυασμένων μορφών αυτών των πολυπεπτιδίων, αντισώματα που παράγονται εναντίον αυτών των πολυπεπτιδίων, κατατετμημένα πεπτίδια που προέρχονται απ' αυτά τα πολυπεπτίδια, και χρήσεις των ανωτέρω.
CY20071101061T 1998-11-13 2007-08-08 Dna και πολυπεπτιδια ανθρωπινης tslp CY1106806T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10845298P 1998-11-13 1998-11-13
PCT/US1999/027069 WO2000029581A1 (en) 1998-11-13 1999-11-12 Human tslp dna and polypeptides

Publications (1)

Publication Number Publication Date
CY1106806T1 true CY1106806T1 (el) 2012-05-23

Family

ID=22322307

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071101061T CY1106806T1 (el) 1998-11-13 2007-08-08 Dna και πολυπεπτιδια ανθρωπινης tslp

Country Status (14)

Country Link
US (8) US6555520B2 (el)
EP (1) EP1129190B2 (el)
JP (3) JP4454859B2 (el)
AT (1) ATE362534T2 (el)
AU (1) AU755562B2 (el)
CA (1) CA2349762C (el)
CY (1) CY1106806T1 (el)
DE (1) DE69936105T3 (el)
DK (1) DK1129190T4 (el)
ES (1) ES2288036T5 (el)
IL (3) IL143034A0 (el)
NZ (1) NZ512105A (el)
PT (1) PT1129190E (el)
WO (1) WO2000029581A1 (el)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030099947A1 (en) 1998-09-21 2003-05-29 Bazan J. Fernando Mammalian cytokines; related reagents and methods
EP1897949B1 (en) * 1998-09-21 2014-11-12 Merck Sharp & Dohme Corp. Human interleukin-B50. Therapeutic uses
PT1129190E (pt) 1998-11-13 2007-08-08 Immunex Corp Adn e polipéptidos de tslp humanos.
US6890734B2 (en) * 2000-11-10 2005-05-10 Schering Corporation Nucleic acids encoding a cytokine receptor complex
PT1417231E (pt) 2001-07-23 2013-07-29 Immunex Corp Linfopoietina estromal tímica humana modificada
AU2003208888B2 (en) * 2002-02-01 2006-10-19 Merck Sharp & Dohme Llc Uses of mammalian cytokine; related reagents
ATE407691T1 (de) * 2003-07-18 2008-09-15 Schering Corp Behandlung und diagnose von neoplasien mit tslp (thymic stromal lymphopoietin)
US20050249712A1 (en) 2004-03-23 2005-11-10 The Government Of The Usa As Represented By The Secretary Of The Dept. Of Health & Human Services Methods for use of TSLP and agonists and antagonists thereof
WO2006023226A2 (en) * 2004-07-28 2006-03-02 Tanox, Inc. Thymic stromal lymphopoietin promoter and uses therefor
US20060171943A1 (en) * 2005-02-01 2006-08-03 Amgen Inc. Compositions and methods of treating fibrotic disorders
CA2513350A1 (en) * 2005-03-02 2006-09-02 Sydney West Area Health Service Treatment for multiple sclerosis
CN101370831B (zh) * 2006-01-13 2013-06-19 Irm责任有限公司 用于治疗过敏性疾病的针对胸腺基质淋巴细胞生成素受体的抗体
GB0603683D0 (en) 2006-02-23 2006-04-05 Novartis Ag Organic compounds
SE532251C2 (sv) * 2006-11-28 2009-11-24 Theravac Pharmaceuticals Ab Nya formuleringar av TSLP för behandling av TH2-medierade inflammatoriska sjukdomar genom vaccinering
WO2008076321A1 (en) 2006-12-14 2008-06-26 Schering Corporation Engineered anti-tslp antibody
CA2671865C (en) * 2006-12-14 2017-01-10 Schering-Plough Ltd. Canine thymic stromal lymphopoietin protein and uses thereof
US8501678B2 (en) 2007-03-06 2013-08-06 Atara Biotherapeutics, Inc. Variant activin receptor polypeptides and uses thereof
TW201718635A (zh) 2007-03-06 2017-06-01 安美基公司 變異之活動素受體多肽及其用途
US7982016B2 (en) 2007-09-10 2011-07-19 Amgen Inc. Antigen binding proteins capable of binding thymic stromal lymphopoietin
WO2010062383A2 (en) 2008-11-26 2010-06-03 Amgen Inc. Stabilized receptor polypeptides and uses thereof
EP2213682A1 (en) 2009-01-30 2010-08-04 Institut Curie TSLP promotes immune evasion and persistence of viruses
NZ599761A (en) 2009-11-04 2014-04-30 Merck Sharp & Dohme Engineered anti-tslp antibody
SG11201403367YA (en) 2011-12-19 2014-07-30 Amgen Inc Variant activin receptor polypeptides, alone or in combination with chemotherapy, and uses thereof
AR090915A1 (es) 2012-05-04 2014-12-17 Intervet Int Bv Proteina de fusion de proteina linfopoyetina estromal timica canina con la region fc de igg
WO2014074815A1 (en) * 2012-11-09 2014-05-15 Melnick Ari Small molecule inhibitors of malt1
UY35148A (es) 2012-11-21 2014-05-30 Amgen Inc Immunoglobulinas heterodiméricas
CA2899889A1 (en) 2013-02-01 2014-08-07 Santa Maria Biotherapeutics, Inc. Administration of an anti-activin-a compound to a subject
US9708375B2 (en) 2013-03-15 2017-07-18 Amgen Inc. Inhibitory polypeptides specific to WNT inhibitors
WO2014162007A2 (en) * 2013-04-04 2014-10-09 Ieo - Istituto Europeo Di Oncologia Srl Thymic stromal lymphopoietin fragments and uses thereof
EP3041863A4 (en) 2013-09-05 2017-08-16 Amgen Inc. Fc-containing molecules exhibiting predictable, consistent, and reproducible glycoform profiles
EP3467501B1 (en) 2014-05-16 2020-11-04 Amgen Inc. Assay for detecting th1 and th2 cell populations
KR20170035891A (ko) 2014-06-13 2017-03-31 산타 마리아 바이오테라퓨틱스, 인코포레이티드 제형화된 수용체 폴리펩타이드 및 관련 방법
KR101843248B1 (ko) 2015-03-17 2018-03-29 고려대학교 세종산학협력단 흉선 기질 림프단백질 매개 신호전달을 제어하는 펩타이드 유도체 및 이를 포함하는 알러지 및 천식 질환 예방 및 치료용 약학 조성물
WO2016148437A1 (ko) * 2015-03-17 2016-09-22 고려대학교 산학협력단 흉선 기질 림프단백질 매개 신호전달을 제어하는 펩타이드 유도체 및 이를 포함하는 알러지 및 천식 질환 예방 및 치료용 약학 조성물
EA038332B1 (ru) 2015-09-09 2021-08-10 Новартис Аг Молекулы, связывающиеся с тимусным стромальным лимфопоэтином (tslp), и способы применения таких молекул
RU2731644C2 (ru) 2015-09-09 2020-09-07 Новартис Аг Молекулы, связывающиеся с тимусным стромальным лимфопоэтином (tslp), и способы применения таких молекул
EP3596225A1 (en) 2017-03-14 2020-01-22 Amgen Inc. Control of total afucosylated glycoforms of antibodies produced in cell culture
JP2021519068A (ja) 2018-03-26 2021-08-10 アムジェン インコーポレイテッド 細胞培養において産生される抗体の総非フコシル化グリコフォーム
CN109678957B (zh) * 2018-12-06 2021-04-06 浙江工业大学 一种抗人tslp单克隆抗体及其制备与应用
KR102156335B1 (ko) * 2018-12-28 2020-09-16 (주)메디톡스 외래 단백질을 발현하는 미생물, 및 그의 용도
MX2022003461A (es) 2019-09-26 2022-04-19 Amgen Inc Metodos de produccion de composiciones de anticuerpos.
WO2021247892A1 (en) 2020-06-04 2021-12-09 Amgen Inc. Assessment of cleaning procedures of a biotherapeutic manufacturing process
US20240043501A1 (en) 2020-10-15 2024-02-08 Amgen Inc. Relative unpaired glycans in antibody production methods
TW202317614A (zh) 2021-06-07 2023-05-01 美商安進公司 使用岩藻糖苷酶控制糖基化蛋白的去岩藻糖基化水平
CA3233279A1 (en) 2021-10-05 2023-04-13 Amgen, Inc. Fc-gamma receptor ii binding and glycan content
WO2023215725A1 (en) 2022-05-02 2023-11-09 Fred Hutchinson Cancer Center Compositions and methods for cellular immunotherapy

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5011912A (en) * 1986-12-19 1991-04-30 Immunex Corporation Hybridoma and monoclonal antibody for use in an immunoaffinity purification system
ES2142341T3 (es) 1992-04-30 2000-04-16 Amgen Inc Metodos de tratamiento de las enfermedades inducidas por la interleuquina-1 y el factor de necrosis tumoral.
EP0737071A1 (en) 1993-06-15 1996-10-16 Il- Yang Pharm. Co., Ltd. Anti-sense oligodeoxynucleotide to fibrogenic cytokines and use thereof
GB9702944D0 (en) 1997-02-13 1997-04-02 Univ Manchester Reducing fibrosis
US6844170B1 (en) * 1998-03-19 2005-01-18 Human Genome Sciences, Inc. Cytokine receptor common gamma chain like
EP1093457B8 (en) 1998-03-19 2011-02-02 Human Genome Sciences, Inc. Cytokine receptor common gamma chain like
US6982320B2 (en) 1998-03-19 2006-01-03 Human Genome Sciences, Inc. Cytokine receptor common gamma chain like
US20030099947A1 (en) * 1998-09-21 2003-05-29 Bazan J. Fernando Mammalian cytokines; related reagents and methods
EP1897949B1 (en) * 1998-09-21 2014-11-12 Merck Sharp & Dohme Corp. Human interleukin-B50. Therapeutic uses
PT1129190E (pt) 1998-11-13 2007-08-08 Immunex Corp Adn e polipéptidos de tslp humanos.
WO2000039149A2 (en) 1998-12-30 2000-07-06 Millennium Pharmaceuticals, Inc. Secreted proteins and uses thereof
US20010021380A1 (en) 1999-04-19 2001-09-13 Pluenneke John D. Soluble tumor necrosis factor receptor treatment of medical disorders
EP2329842A3 (en) 2000-05-12 2011-07-27 Immunex Corporation Interleukin-1 inhibitors in the treatment of diseases
AU2001271624A1 (en) 2000-06-28 2002-01-08 Whitehead Institute For Biomedical Research Thymic stromal lymphopoietin receptor molecules and uses thereof
JP2004519205A (ja) 2000-06-28 2004-07-02 アムジェン インコーポレイテッド 胸腺間質リンホポイエチンレセプター分子およびその使用
AU2003208888B2 (en) * 2002-02-01 2006-10-19 Merck Sharp & Dohme Llc Uses of mammalian cytokine; related reagents
HRP20020453A2 (en) 2002-05-23 2003-12-31 Pliva D D 1,3-diaza-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediate for preparation thereof
CN100471871C (zh) 2002-09-06 2009-03-25 安姆根有限公司 治疗性人抗－il－1r1单克隆抗体
ATE407691T1 (de) 2003-07-18 2008-09-15 Schering Corp Behandlung und diagnose von neoplasien mit tslp (thymic stromal lymphopoietin)
US20050249712A1 (en) * 2004-03-23 2005-11-10 The Government Of The Usa As Represented By The Secretary Of The Dept. Of Health & Human Services Methods for use of TSLP and agonists and antagonists thereof
US20060039910A1 (en) 2004-08-20 2006-02-23 Amgen Inc. Methods and compositions for treating allergic inflammation
CN101370831B (zh) 2006-01-13 2013-06-19 Irm责任有限公司 用于治疗过敏性疾病的针对胸腺基质淋巴细胞生成素受体的抗体
GB0603683D0 (en) * 2006-02-23 2006-04-05 Novartis Ag Organic compounds
WO2008076321A1 (en) 2006-12-14 2008-06-26 Schering Corporation Engineered anti-tslp antibody
AR067045A1 (es) 2007-06-20 2009-09-30 Irm Llc Metodos y composiciones para el tratamiento de enfermedades alergicas
US9157749B2 (en) † 2011-04-11 2015-10-13 Clarion Co., Ltd. Position calculation method and position calculation apparatus

Also Published As

Publication number Publication date
US7405058B2 (en) 2008-07-29
IL143034A0 (en) 2002-04-21
AU755562B2 (en) 2002-12-12
IL195812A0 (en) 2011-08-01
US20020146819A1 (en) 2002-10-10
DK1129190T4 (en) 2017-04-03
US20120014961A1 (en) 2012-01-19
ES2288036T3 (es) 2007-12-16
PT1129190E (pt) 2007-08-08
EP1129190B2 (en) 2017-01-11
ES2288036T5 (es) 2017-07-06
JP2002530079A (ja) 2002-09-17
CA2349762A1 (en) 2000-05-25
US20090017034A1 (en) 2009-01-15
IL143034A (en) 2009-07-20
JP2013078331A (ja) 2013-05-02
ATE362534T2 (de) 2007-06-15
AU1726600A (en) 2000-06-05
DE69936105T3 (de) 2017-07-27
JP2010088445A (ja) 2010-04-22
US8444979B2 (en) 2013-05-21
US9346870B2 (en) 2016-05-24
JP5632155B2 (ja) 2014-11-26
CA2349762C (en) 2013-12-24
US20150005226A1 (en) 2015-01-01
US20100266601A1 (en) 2010-10-21
US6555520B2 (en) 2003-04-29
US20130225490A1 (en) 2013-08-29
US7786271B2 (en) 2010-08-31
JP4454859B2 (ja) 2010-04-21
NZ512105A (en) 2004-04-30
US20030181360A1 (en) 2003-09-25
US20060223754A1 (en) 2006-10-05
WO2000029581A1 (en) 2000-05-25
DE69936105T2 (de) 2008-01-24
DE69936105D1 (de) 2007-06-28
EP1129190A1 (en) 2001-09-05
DK1129190T3 (da) 2007-09-24
US7304144B2 (en) 2007-12-04
IL195812A (en) 2012-04-30
EP1129190B1 (en) 2007-05-16

Similar Documents

Publication Publication Date Title
CY1106806T1 (el) Dna και πολυπεπτιδια ανθρωπινης tslp
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
DE69926480D1 (de) Acpl dna und polypeptide
ATE292685T1 (de) Herstellung und verwendung von rekombinanten influenza a virus m2 konstruktionen und impstoffe
EP2258383A3 (en) Antigenic peptides derived from telomerase
FI961251A0 (fi) Ihmisten metabotrooppiset glutamaattireseptorialatyypit(HMR4, HMR6, HMR7)ja niihin liittyvät DNA-yhdisteet
CO5050400A1 (es) Proteina de chlamydia, secuencia de genes y anticuerpos para ello
AU6160201A (en) Human polypeptides causing or leading to the killing of cells including lymphoidtumor cells
ATE394484T1 (de) Smad 6 und dessen anwendungen
ATE368688T1 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
BR9710975A (pt) Genes de proteìna de adesão de superfìcie exposta de 120 kda imunodominante de ehrlichia chaffeensis
CY1105405T1 (el) Dna και πολυπεπτιδια il-1ζ, παραλλαγων ματισματος il-1ζ και xrec2
FR2692282B1 (fr) Clonage du gene codant pour la proteine gp28.5 de t. gondii; fragments peptidiques issus de ladite proteine et leurs applications.
CY1105226T1 (el) Dna και πολυπεπτιδια il-1 εψιλον ανθρωπου
ATE354657T1 (de) Basb019 proteine und gene aus moraxella catarrhalis, antigene, antikörper, und verwendungen
WO1999041388A3 (en) Metalloprotease-disintegrins svph3-13 and svph3-17 dna and polypeptides
WO2002090500A3 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
ATE281524T1 (de) Moraxella catarrhalis pilq proteine
ATE341628T1 (de) Proteine und gene aus moraxella catarrhalis, antigene, antikörper, und verwendungen
DE60124380D1 (de) Angiogenese-assoziierte proteine und dafür kodierende nukleinsäure
WO2002046408A3 (en) Human proteins, polynucleotides encoding them and methods of using the same
WO2002081629A3 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
WO2002072770A3 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
WO2002038765A3 (en) Dna encoding bovine immunoglobulin a inducing protein and uses therefor
WO2002098900A3 (en) Novel human proteins, polynucleotides encoding them and methods of using the same